"The average American has come of age with remarkable medical advances - from the polio vaccine, to multi-organ transplants, to the real prospect of nerve regeneration. Regenerative medicine, with its promise of repairing damaged tissues and growing replacement tissues and whole organs, is the new frontier." -2020: A New Vision. A Future for Regenerative Medicine, U.S. Department of Health and Human Services
Methuselah Foundation was co-founded by Dave Gobel and Aubrey de Grey in 2003 to shed light on the processes of aging and finds ways to extend healthy life. Since then, we've given over $4 million in funding for regenerative medicine R&D. From tissue engineering to stem cell science, we've seen explosive progress in the industry, and we're more convinced than ever that regenerative medicine will transform health care in the 21st century.
For us, tackling aging is really about changing assumptions regarding what is and isn't possible for human life, health, and happiness. We believe that aging as we currently know it is not inevitable. We think everyone should enjoy a vibrant and productive life, not just in their early years, but into their 70s, 80s, and 90s. Through regenerative medicine, we can envision cures for many of today's most debilitating conditions, from heart disease and diabetes to renal failure and neurodegenerative disorders. By 2030, 90 year olds can be as healthy as 50 year olds are today.
We see opportunities to build towards that future all around us, but regenerative medicine needs help. The field of tissue engineering, for example, currently receives less than $500 million in federal funding annually, compared to $5 billion for cancer and almost $3 billion for HIV/AIDS. That's not only shortsighted, but irresponsible. We have to bridge this funding gap, increase awareness, and ignite public demand for progress.
Every day, we think about how to make the seemingly impossible become the inevitable. Unlike many nonprofits, we're responsive, not prescriptive, in our approach. We're project - rather than program - based, and we're always on the lookout for high-leverage interventions that spur concrete progress in the short term - and generate ripple effects over time.
Like us, many of our donors and partners are not just doers but dreamers, disruptors, iconoclasts. Over the last decade, we've helped put regenerative medicine on the map as a source of comprehensive solutions for age-related disease, disability, and suffering. Now, it's time to do more. When we scan the landscape of contemporary medicine, we see dramatic advances on the horizon, and we feel compelled to plant seeds in both expected and unexpected places. We'd love for you to join us.
Co-founder and CEO
A forward-thinking entrepreneur and father, Dave co-founded Methuselah in 2003 with Dr. Aubrey de Grey. He continues to work tirelessly to advance breakthroughs that will extend healthy life.
Dane manages daily operations for Methuselah, overseeing finances and coordinating all projects, with a particular focus on organizational strategy and media production.
Executive Director, MPrize
Kevin is Executive Director of the Mprize, founder of AgeNet and co-founder of SENS Research Foundation, and is currently working on the role of cellular senescence in degenerative disease at the Buck Institute for Research on Aging.
Ross is a freelance writer, poet, and environmental journalist. Before joining Methuselah, he spent eight years as senior editor of EnlightenNext magazine. Ross writes our blog, newsletters, and major communications pieces.
Social Media Manager
With 10 years of experience in social media, Florina spearheads Methuselah's online community building and manages our daily presence on Twitter and Facebook, tracking down the latest news in regenerative medicine.
Full Stack Developer
Bjorn serves as the technical lead for Methuselah Foundation and New Organ's digital platforms and tools, building and maintaining websites, databases, and backend services.
Ting designs Methuselah's brand and materials. She is a fellow at the Long Now Foundation and co-founder of the Meraki Collective.
Donor Outreach Coordinator
Emilie manages our donor outreach programs. She studied English literature at University of Wisconsin-Madison, volunteers with various youth groups, and is currently exploring opportunities to pursue counseling or social work.
Dr. Anthony Atala
Director, Wake Forest Institute for Regenerative Medicine
Dr. Stephen Badylak
Deputy Dir., McGowan Institute for Regenerative Medicine
Dr. Christopher Breuer
Co-Dir., Tissue Engineering at Nationwide Children's Hospital
Dr. Karen Christman
Assoc. Prof., Sanford Consortium for Regenerative Medicine
Dr. Scott Collins
CTO & Vice President of R&D, TeVido Biodevices
Dr. Raymond Chung
Dir. of Hepatology, Medicine Service, Mass General
Dr. Paolo De Coppi
Clinical Reader & Head of Surgery Unit, University College of London
Dr. Jonathan Epstein
William Wikoff Smith Professor of Cardiovascular Research, UPenn
Dr. Gabor Forgacs
Scientific Founder, Organovo, Co-Founder, Modern Meadow
Dr. Wolfram Goessling
Asst. Prof., Dept. of Medicine, Harvard Medical School
Dr. Valerie Gouon-Evans
Assistant Professor, Mount Sinai School of Medicine
Dr. Armand Keating
Director, Cell Therapy Program, Princess Margaret Hospital
Dr. Eric Lagasse
Director, Cancer Stem Cell Center, McGowan Institute
Dr. Robert Langer
David H. Koch Institute Professor, MIT
Dr. William Wagner
Director, McGowan Institute for Regenerative Medicine
Dr. Chris Mason
Chair, Regenerative Medicine Bioprocessing, UCL
Dr. Jeffrey Molkentin
Professor, Dept. of Pediatrics, Cincinnati Children's Hospital
Dr. Robert Nerem
Institute Professor Emeritus, Georgia Institute of Technology
Dr. Laura Niklason
Professor of Anesthesiology & Biomedical Engineering, Yale
Dr. Harald Ott
Instructor in Surgery, Harvard Medical School
Dr. Andre Terzic
Director, Center for Regenerative Medicine at the Mayo Clinic
Dr. Korkut Uygun
Assistant Professor in Surgery, Harvard Medical School
Dr. Joseph P. Vacanti
Surgeon in Chief, Mass General Hospital for Children
Mr. William Hinman
Exec Dir., Regenerative Medicine Foundation
Mr. Keith Murphy
CEO of Viscient Biosciences, Founder & Chairman Emeritus of Organovo
Dr. Cathy Prescott
Founding Dir., Biolatris, Co-Founder, univerCELLmarket
Dr. Alan Russell
Exec Dir., Pittsburgh Tissue Engineering Initiative
Mr. Bernard Siegel
Founder & Exec Dir., Genetics Policy Institute
Organovo is an industry leader in 3D printing of functional human tissues, and has been partnered with Methuselah since its inception. We are currently working to provide 3D bioprinters to top research universities.Learn more about Organovo >
Institute of Competition Sciences
The Institute of Competition Sciences (ICS) manages the strategy, design, and operations of the New Organ initiative. ICS specializes in large-scale incentivized innovation programs and has supported corporate, government, and non-profit prizes totaling more than $9,000,000.Learn more about ICS >
World Stem Cell Summit
WSCS is a premier annual forum for regenerative medicine and the official launch venue for the New Organ Liver Prize. Together, we're seeking to contribute to the realization of whole organ engineering, preservation, and regeneration for the benefit of millions.Learn more about WSCS >
Sens Research Foundation
SENS and Methuselah have a shared history based on the partnership of Dave Gobel and Aubrey de Grey, who founded Methuselah together in 2003. When they decided to spin SENS off as an independent organization focused on rejuvenation biotechnologies in 2009, we became its fiscal sponsor.Learn more about SENSRF >
Click on the link to view the PDF of our finances from that year.